Journal
BIOMATERIALS SCIENCE
Volume 5, Issue 10, Pages 2159-2168Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c7bm00623c
Keywords
-
Categories
Funding
- Australian Research Council Centre of Excellence Scheme [CE 140100012]
- ARC [FL110100196]
Ask authors/readers for more resources
Despite significant progress in developing new drugs for seizure control, epilepsy still affects 1% of the global population and is drug-resistant in more than 30% of cases. To improve the therapeutic efficacy of epilepsy medication, a promising approach is to deliver anti-epilepsy drugs directly to affected brain areas using local drug delivery systems. The drug delivery systems must meet a number of criteria, including high drug loading efficiency, biodegradability, neuro-cytocompatibility and predictable drug release profiles. Here we report the development of fibre-and sphere-based microcapsules that exhibit controllable uniform morphologies and drug release profiles as predicted by mathematical modelling. Importantly, both forms of fabricated microcapsules are compatible with human brain derived neural stem cells and differentiated neurons and neuroglia, indicating clinical compliance for neural implantation and therapeutic drug delivery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available